Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May

  • Sanofi SA (NASDAQ:SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business.
  • Sanofi shareholders will receive one EUROAPI share for 23 shares held in the parent company.
  • The company confirmed plans to conserve a 30% stake in the business after the listing, while EPIC Bpifrance will buy a 12% stake for up to €150 million.
  • L'Oreal SA (OTC:LRLCY), Sanofi's largest shareholder, agreed to a one-year lock-up period after the listing, Sanofi added.
  • EUROAPI makes active pharmaceutical ingredients (APIs) for medicines and draws on six production sites in Italy, Germany, Britain, France, and Hungary.
  • It offers approximately 200 APIs and Contract Development and Manufacturing Organization (CDMO) activities.
  • EUROAPI recorded consolidated revenue of €893 million in 2021, with a core EBITDA of €72 million. Sales to Sanofi amounted to €407 million in 2021.
  • Price Action: SNY shares are up 1.91% at $52.32 during the market session on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.